Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | Ekblom Anders Director | 64,471 | $0 | 64,471 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | Jacquet Pierre Director | 60,553 | $0 | 60,553 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | Yoskowitz Marc J Director | 59,139 | $0 | 59,139 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | PAKIANATHAN DEEPIKA Director | 45,000 | $0 | 45,000 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | WYZGA MICHAEL S Director | 75,783 | $0 | 75,783 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | Shames Daniel Director | 59,139 | $0 | 59,139 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | Jenkins Annalisa Director | 59,947 | $0 | 59,947 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-09 4:15 pm | N/A 2034-02-08 | Mereo BioPharma Group plc | MREO | Bender Jeremy Director | 61,361 | $0 | 61,361 (Direct) | View |
| 2024-01-25 Option Award | 2024-01-26 4:15 pm | N/A 2034-01-25 | Mereo BioPharma Group plc | MREO | Sermon Charles General Counsel | 245,000 | $0 | 245,000 (Direct) | View |
| 2024-01-25 Option Award | 2024-01-26 4:15 pm | N/A 2034-01-25 | Mereo BioPharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer | 850,000 | $0 | 850,000 (Direct) | View |
| 2024-01-25 Option Award | 2024-01-26 4:15 pm | N/A 2034-01-25 | Mereo BioPharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks | 196,000 | $0 | 196,000 (Direct) | View |
| 2024-01-25 Option Award | 2024-01-26 4:15 pm | N/A 2034-01-25 | Mereo BioPharma Group plc | MREO | Lewicki John A. Chief Scientific Officer | 137,000 | $0 | 137,000 (Direct) | View |
| 2024-01-25 Option Award | 2024-01-26 4:15 pm | N/A 2034-01-25 | Mereo BioPharma Group plc | MREO | Fox Christine Ann Chief Financial Officer | 245,000 | $0 | 245,000 (Direct) | View |
Ownership | 2024-01-02 4:20 pm | N/A N/A | Mereo Biopharma Group plc | MREO | Ekblom Anders Director | 0 | $0 | 369,948 (Indirect) | View |
Ownership | 2024-01-02 4:18 pm | N/A N/A | Mereo Biopharma Group plc | MREO | Sermon Charles General Counsel | 0 | $0 | 1,415,850 (Direct) | View |
Ownership | 2024-01-02 4:17 pm | N/A 2032-12-01 | Mereo Biopharma Group plc | MREO | Shames Daniel Director | 0 | $0 | 128,944 (Direct) | View |
Ownership | 2024-01-02 4:16 pm | N/A N/A | Mereo Biopharma Group plc | MREO | Hughes-Wilson Alexandra See Remarks | 0 | $0 | 701,649 (Direct) | View |
Ownership | 2024-01-02 4:16 pm | N/A 2029-05-20 | Mereo Biopharma Group plc | MREO | PAKIANATHAN DEEPIKA Director | 0 | $0 | 163,500 (Direct) | View |
Ownership | 2024-01-02 4:15 pm | N/A N/A | Mereo Biopharma Group plc | MREO | Fox Chrisitne Ann Chief Financial Officer | 0 | $0 | 925,000 (Direct) | View |
Ownership | 2024-01-02 4:15 pm | N/A 2032-12-01 | Mereo Biopharma Group plc | MREO | Jenkins Annalisa Director | 0 | $0 | 132,473 (Direct) | View |
Ownership | 2024-01-02 4:15 pm | N/A N/A | Mereo Biopharma Group plc | MREO | Lewicki John A. Chief Scientific Officer | 0 | $0 | 713,199 (Indirect) | View |
Ownership | 2024-01-02 4:15 pm | N/A N/A | Mereo Biopharma Group plc | MREO | Scots-Knight Denise Chief Executive Officer | 0 | $0 | 4,459,512 (Direct) | View |
Ownership | 2024-01-02 4:15 pm | N/A 2029-05-20 | Mereo Biopharma Group plc | MREO | WYZGA MICHAEL S Director | 0 | $0 | 380,796 (Direct) | View |
Ownership | 2024-01-02 4:15 pm | N/A 2032-02-01 | Mereo Biopharma Group plc | MREO | Jacquet Pierre Director | 0 | $0 | 237,174 (Direct) | View |
Ownership | 2024-01-02 4:15 pm | N/A 2032-12-01 | Mereo Biopharma Group plc | MREO | Yoskowitz Marc J Director | 0 | $0 | 124,287 (Direct) | View |
Ownership | 2024-01-02 4:15 pm | N/A 2031-01-19 | Mereo Biopharma Group plc | MREO | Bender Jeremy Director | 0 | $0 | 263,946 (Direct) | View |
Ownership | 2024-01-02 4:00 pm | N/A N/A | Mereo Biopharma Group plc | MREO | Rubric Capital Management LP Rosen David Efraim 10% Owner | 0 | $0 | 99,714,985 (Indirect) | View |